Recro Pharma CFO Ryan Lake's 2020 pay jumps 161% to $2.2M
Recro Pharma reports 2020 executive compensation
By ExecPay News
Published: March 25, 2021
Recro Pharma reported fiscal year 2020 executive compensation information on March 25, 2021.
In 2020, three executives at Recro Pharma received on average a compensation package of $1.2M, a 47% decrease compared to previous year.
Average pay of disclosed executives at Recro Pharma
Ryan D. Lake, Chief Financial Officer, received $2.2M in total, which increased by 43% compared to 2019. 48% of Lake's compensation, or $1.1M, was in stock awards. Lake also received $48K in bonus, $108K in non-equity incentive plan, $744K in option awards, $199K in salary, as well as $25K in other compensation.
J. David Enloe, Jr, Chief Executive Officer, received a compensation package of $1.1M. 62% of the compensation package, or $660K, was in stock awards.
Gerri Henwood, Chief Executive Officer, earned $441K in 2020, a 90% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on March 25, 2021.